In vitro activity of N-formimidoyl thienamycin against 98 clinical isolates of Brucella melitensis compared with those of cefoxitin, rifampin, tetracycline, and co-trimoxazole.
AUTOR(ES)
Gutiérrez Altés, A
RESUMO
IN vitro susceptibilities of 98 isolates of Brucella melitensis to N-formimidoyl thienamycin, tetracycline, co-trimoxazole, rifampin, and cefoxitin were determined. N-Formimidoyl thienamycin showed good activity which was similar to those of tetracycline and rifampin and different from that of the other beta-lactam antibiotic tested (cefoxitin), which showed poor activity. Co-trimoxazole showed good activity.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=181922Documentos Relacionados
- N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.
- N-formimidoyl thienamycin (MK0787): in vitro study.
- Activity of N-formimidoyl thienamycin and cephalosporins against isolates from nosocomially acquired bacteremia.
- In vitro activity of N-formimidoyl thienamycin (MK0787).
- Urinary Recovery of N-Formimidoyl Thienamycin (MK0787) as Affected by Coadministration of N-Formimidoyl Thienamycin Dehydropeptidase Inhibitors